The SMA treatment program is complete, in line with standards. Patients have access to all registered therapies, Deputy Health Minister Marek Kos told the Sejm on Thursday. Outlays for the program are increasing, he reported. This year, PLN 475 million has already been spent, while in the entire previous year, PLN 444 million was spent.
Kos provided information to MPs, answering questions posed by a group of Civic Coalition MPs. Among other things, the MPs asked about guarantees of funding for the drug program for patients with spinal muscular atrophy (SMA), although in recent months representatives of the Health Ministry have repeatedly stressed that the stability of funding is not at risk - this applies both to patients diagnosed with SMA and those covered by the program. - On behalf of everyone, we...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
